1196P Pre-existing and acquired mechanisms of resistance to lorlatinib in previously treated patients (pts) with ALK+ advanced non-small cell lung cancer (NSCLC)

Autor:	Alessandra Bearz, Antonello Abbattista, S-H.I. Ou, Benjamin Besse, Ross A. Soo, Alice T. Shaw, D.R. Camidge, D. Shepard, Benjamin Solomon, Enriqueta Felip, Eng Huat Tan, Takashi Seto, Todd M. Bauer, J.-F. Martini, F. Toffalorio, Santiago Viteri
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty business.industry Internal medicine Medicine non-small cell lung cancer (NSCLC) Hematology business Previously treated medicine.disease Lorlatinib
Zdroj:	Annals of Oncology. 32:S955
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2021.08.1801
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9294d5f27333a3b05532e0577d9186ac https://doi.org/10.1016/j.annonc.2021.08.1801 Zobrazit plný text záznamu